IgA levels were higher in participants reporting COVID-19-compatible symptoms in the previous months than in those reporting being asymptomatic (p = 0.041) (Fig. 3c), and among symptomatic individuals, duration of symptoms >10 days was associated with higher IgM levels (p = 0.022) (Fig. 3d). The gene discussed is CD40LG; the disease is COVID-19.